SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-002523
Accepted
2022-08-29 00:15:12
Documents
1
Effectiveness Date
2022-08-26
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 593
  Complete submission text file 9999999995-22-002523.txt   1855
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-266984 | Film No.: 221207041
SIC: 2834 Pharmaceutical Preparations